Gold, silver weaker on profit taking, less risk aversion — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL Kitco — July 24, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
Lazard, Inc. (NYSE:LAZ ) Q2 2025 Earnings Conference Call July 24, 2025 8:00 AM ET Company Participants Alexandra M. Deignan - Head of Treasury & IR Evan Lawrence Russo - Chief Executive Officer of Asset Management Mary Ann Betsch - Chief Financial Officer Peter R.
Alphabet: You'll Regret Not Getting On The AI Train — Positive
GOOG GOOGL Seeking Alpha — July 24, 2025Alphabet Inc.'s Q2 results crushed expectations, driven by surging AI demand and explosive cloud profit growth, especially in operating margins. Google raised its AI-driven CAPEX forecast from $75B to $85B, signaling huge confidence in future AI-led profitability. Alphabet trades at a significant valuation discount to cloud peers like Amazon and Microsoft, despite superior cloud operating profit up-scaling.
Investors Really Don't Like What They Saw in Chipotle's Second-Quarter Earnings — Negative
CMG Investopedia — July 24, 2025Investors are souring on Chipotle. We don't mean its sour cream.
Blackstone Results Pop on Higher Fees, Assets Under Management — Positive
BX Investopedia — July 24, 2025Blackstone (BX) shares gained after the investment management firm posted better-than-expected results and raised its dividend as fees and assets under management (AUM) took off.
Sysco's Q4 Earnings on the Horizon: What Surprise Awaits Investors? — Positive
SYY Zacks Investment Research — July 24, 2025SYY's Q4 gains likely stem from U.S. Foodservice strength, global growth moves and sharper cost efficiencies.
What's in the Cards for Arch Capital This Earnings Season? — Positive
ACGL Zacks Investment Research — July 24, 2025ACGL's Q2 results are likely to reflect rate increases, new business opportunities, growth in invested asset base, and improved pricing.
The ECB just pressed pause on rate cuts. The next move isn't clear. — Neutral
BBEU DBEF DBEU DFE EDEN EPOL EWD EWG EWI EWL EWN EWP EWQ EWU EZU FDD FEP FEZ FLGB HEDJ HEZU IEUR IEV SPEU VGK Market Watch — July 24, 2025ECB President Christine Lagarde left economists and investors a little less certain as to when, or perhaps even whether, further easing will arrive.
USANA Health Sciences is resurfacing as an idea after a strong Q2 report. The direct selling business has continued to struggle with a decline in sales and active customers. A segment turnaround remains uncertain. The previous Hiya acquisition's potential is clearly showing. Operational expansion underlines massive long-term potential for USANA.
NextEra Energy: A Dividend Aristocrat SWAN That Should Fly Higher — Positive
NEE Seeking Alpha — July 24, 2025NextEra Energy has reliably grown its payout to shareholders for 30 years. NEE also appears to be positioned for high-single-digit annual adjusted EPS growth for the foreseeable future. The company has the financial strength to capitalize on steadily growing electricity demand.
WST Stock Rises on Q2 Earnings Beat, EPS View Up on Tariff & FX Benefit — Positive
WST Zacks Investment Research — July 24, 2025West Pharmaceutical's second-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
Will lululemon's Innovation Pipeline Deliver Growth in 2H25? — Neutral
LULU Zacks Investment Research — July 24, 2025LULU bets big on technical gear and global reach to spark 2H25 growth amid cost pressures and cautious U.S. demand.
DOW Lags Q2 Earnings and Sales Estimates on Lower Prices — Negative
DOW Zacks Investment Research — July 24, 2025DOW posts a wider-than-expected Q2 loss and misses sales targets as pricing pressure and volume declines weigh on results.
Bristol Myers Gains 6.3% in a Month: Buy, Sell or Hold the Stock? — Neutral
BMY Zacks Investment Research — July 24, 2025BMY rises 6.3% in a month as investors pin hopes on new drugs to offset pressure from pipeline and patent losses.
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market — Positive
LH Zacks Investment Research — July 24, 2025LH tops Q2 estimates with double-digit EPS growth, margin gains and a raised 2025 outlook, lifting shares pre-market.
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs — Negative
MOH Zacks Investment Research — July 24, 2025MOH's Q2 earnings lag estimates as rising medical care costs offset gains from premiums and rate hikes.
VANCOUVER, British Columbia and West Palm Beach, FL, July 24, 2025 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI) today announced the Company's Board of Directors has approved a reverse stock split of the Company's issued and outstanding common shares whereby every nine (9) shares of its outstanding common shares will automatically be combined into one (1) common share. The reverse split was approved by the Company's shareholders on June 6, 2025 and will be effective as of the commencement of trading on July 28, 2025 at the open of market. As of the close of business …
Texas Instruments Q2 Earnings: Solid Quarter, Still Waiting For A Better Entry Point — Positive
TXN Seeking Alpha — July 24, 2025Texas Instruments Incorporated delivered a solid quarter, with sequential revenue growth and better working capital management, but geopolitical risks and tariffs remain a concern. Management acknowledges some Q2 strength was likely demand pulled forward due to tariffs, and industrial recovery is more robust than automotive. Valuation has run ahead of fundamentals, with the stock trading at a premium not fully justified by current earnings or margin outlook.
Deal-making is likely to rebound in back-half of 2025, says Lazard CEO Peter Orszag — Neutral
LAZ CNBC Television — July 24, 2025Peter Orszag, Lazard CEO, joins 'Money Movers' to discuss Q2 earnings, dealmaking and business in Europe.
CenterPoint Energy Q2 Earnings Miss Estimates, Revenues Improve Y/Y — Negative
CNP Zacks Investment Research — July 24, 2025CNP's Q2 earnings fell short of estimates on higher financing costs, but revenues rose 2% year over year to $1.94 billion.
